COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

PET imaging reveals long-term heart and lung damage from COVID-19
New data highlight the long-lasting effects of the coronavirus, revealing changes that are not detectable by standard medical assessments.
HHS, NIH announce new ‘universal’ vaccine standard for broad-spectrum protection
Currently in development, the “Generation Gold Standard” platform utilizes inert whole viruses to combat more strains of common illnesses, such as COVID and the flu. It’s on track for FDA approval in 2029.
HHS sued over RFK’s $11B cuts to infectious disease control
The Department of Health and Human Services is refusing to allocate funds meant to support state and local healthcare initiatives, as the money stemmed from now-defunct COVID-19 control efforts. A coalition of municipalities is suing to lift the block.
Owner of home healthcare company gets 14 months for defrauding COVID programs
Nakita Cannady, 49, was also convicted of defrauding Cigna to the tune of $194,000, billing the insurer for patient care hours her providers never filled.
Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?
COVID-19 may help explain the increased rates of cardiac and noncardiac mortality among TAVR patients, but there are several other factors to consider as well. Researchers explored nearly 11 years of STS/ACC registry data to learn more.

In a post- or protracted COVID world, no hospital concern will loom larger than patient experience

Improving the patient experience will top the list of hospitals’ strategies for winning and retaining patients in 2021. Not far behind will be facilitating access to care.

Pfizer’s big news: Trump, Biden, stock market all react after COVID-19 vaccine performs well

Pfizer's early vaccine results could represent a key step forward in the race to finally end the COVID-19 pandemic.

Newest hydroxychloroquine data ‘do not support’ use as COVID-19 treatment

This latest analysis compared the outcomes of hospitalized COVID-19 patients treated with hydroxychloroquine and those who received a placebo.

Pain, pride and a renewed sense of purpose: Radiology residents reflect on their time in a COVID care unit

Two trainees with New York-Presbyterian Hospital shared their experiences in Clinical Radiology.

Risk of death, disability after stroke much higher for COVID-19 patients

Experiencing a stroke while your body is already battling COVID-19 can be especially dangerous, this new study suggests.

Health execs implementing AI undaunted by COVID

Almost half the 540-participant cohort is already using at least one form of AI.

Just 6.9% of COVID-related clinical trials are focused on cardiovascular therapies

The study's authors looked at nearly 3,000 clinical trials related to the ongoing pandemic.

Backward tracing busts COVID clusters, as Japan has found and shown

Japan must be doing something in its war on COVID that Western Europe and the United States aren’t doing in their respective homelands.

COVID-19

PET imaging reveals long-term heart and lung damage from COVID-19

HHS, NIH announce new ‘universal’ vaccine standard for broad-spectrum protection

HHS sued over RFK’s $11B cuts to infectious disease control

Owner of home healthcare company gets 14 months for defrauding COVID programs

Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?